Search
AESGP

Statement

AESGP Statement on Regulation (EU) 2024/1860 amending the IVDR and MDR (2024) View
Statement

AESGP Statement on Regulation (EU) 2024/1860 amending the IVDR and MDR (2024)

Read more
AESGP Statement on the European Commission’s legislative proposal amending the IVDR and MDR (2024) View
Statement

AESGP Statement on the European Commission’s legislative proposal amending the IVDR and MDR (2024)

Read more
AESGP Statement on The Revision of EU Pharmaceutical Legislation (2023) View
Statement

AESGP Statement on The Revision of EU Pharmaceutical Legislation (2023)

Read more
AESGP Statement on European Commission’s legislative proposal amending the MDR (2023) View
Statement

AESGP Statement on European Commission’s legislative proposal amending the MDR (2023)

Read more
AESGP Statement on the European Commission’s Communication “Save gas for a safe winter” (2022) View
Statement

AESGP Statement on the European Commission’s Communication “Save gas for a safe winter” (2022)

Read more
AESGP Statement on the MDCG Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices (MDCG 2022 – 5) (2022) View
Statement

AESGP Statement on the MDCG Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices (MDCG 2022 – 5) (2022)

Read more
AESGP Statement on the Medical Devices Regulation's date of application (2021) View
Statement

AESGP Statement on the Medical Devices Regulation's date of application (2021)

Read more
AESGP Reaction to European Beating Cancer Plan (2021) View
Statement

AESGP Reaction to European Beating Cancer Plan (2021)

Read more
AESGP Reaction to European Commission’s Communication on the EU Pharmaceutical Strategy (2020) View
Statement

AESGP Reaction to European Commission’s Communication on the EU Pharmaceutical Strategy (2020)

Read more
AESGP Remarks on EU4Health Programme (2020) View
Statement

AESGP Remarks on EU4Health Programme (2020)

Read more
AESGP Reaction to European Commission’s Roadmap on the Pharmaceutical Strategy (2020) View
Statement

AESGP Reaction to European Commission’s Roadmap on the Pharmaceutical Strategy (2020)

Read more
AESGP Reaction to European Commission’s Farm to Fork Strategy release (2020) View
Statement

AESGP Reaction to European Commission’s Farm to Fork Strategy release (2020)

Read more